Kenji Yamakawa
Amministratore Delegato presso SNBL Clinical Pharmacy Center, Inc.
Profilo
Kenji Yamakawa is currently the Chief Executive Officer at SNBL Clinical Pharmacy Center, Inc. since 2004 and also the Director at SNBL USA Ltd.
since 2010.
He was previously the Director at Shin Nippon Biomedical Laboratories, Ltd.
from 2010 to 2014.
Posizioni attive di Kenji Yamakawa
| Società | Posizione | Inizio |
|---|---|---|
| SNBL Clinical Pharmacy Center, Inc. | Amministratore Delegato | 01/10/2010 |
SNBL USA Ltd.
 SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Direttore/Membro del Consiglio | 01/06/2012 |
Precedenti posizioni note di Kenji Yamakawa
| Società | Posizione | Fine |
|---|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. | Commercial Services |
| Aziende private | 2 |
|---|---|
| SNBL Clinical Pharmacy Center, Inc. | |
SNBL USA Ltd.
SNBL USA Ltd. Medical/Nursing ServicesHealth Services SNBL USA Ltd. provides general toxicology, acute radiation syndrome, apheresis, CNS drug delivery, immunohistochemistry, tissue cross reactivity and biological services. The company is headquartered in Everrett, WA. | Health Services |
- Borsa valori
- Insiders
- Kenji Yamakawa
